NCT00759902View on ClinicalTrials.gov

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

morphine sulfate extended-release capsules

2 x 10 mg, single-dose capsule

DRUG

KADIAN (morphine sulfate extended-release) capsules

1 x 20 mg, single-dose capsule

Trial Locations (1)

78217

CEDRA Clinical Research, LLC, San Antonio

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00759902 - Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions | Biotech Hunter | Biotech Hunter